Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

17-allylamino-17-demethoxygeldanamycin

EU orphan designation number: EU/3/04/256
Active ingredient: 17-allylamino-17-demethoxygeldanamycin
Indication: Treatment of chronic myeloid leukemia
Sponsor: Bristol-Myers Squibb International Corporation
Parc de l’Alliance, Avenue de Finlande 8, B-1420 Braine-l’Alleud, Belgium

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2005 Centralised Orphan - Designation EMEA/OD/079/04 (2005)2650 of 26/01/2005
23/10/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/079/04/T/01 (2008)6243 of 21/10/2008
23/02/2011 Centralised Orphan - Removal of orphan designation from Community Register